Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

Journal of the American Society of Nephrology

Volumn 20, Issue 8, 2009, Pages 1813-1821

  Ninomiya, Toshiharu ^a   Perkovic, Vlado ^a   De Galan, Bastiaan E ^a,b   Zoungas, Sophia ^a   Pillai, Avinesh ^a   Jardine, Meg ^a   Patel, Anushka ^a   Cass, Alan ^a   Neal, Bruce ^a   Poulter, Neil ^c   Mogensen, Carl Erik ^d   Cooper, Mark ^e   Marre, Michel ^f   Williams, Bryan ^g   Hamet, Pavel ^h   Mancia, Giuseppe ⁱ   Woodward, Mark ^a,j   MacMahon, Stephen ^a   Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF MILANO BICOCCA   (Italy)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 68149170224     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008121270     Document Type: Article

References (42)

1. International Diabetes Federation: Diabetes Atlas 2006, 3rd Ed., Brussels, International Diabetes Federation, 2006
2. Asia Pacific Cohort Studies Collaboration: The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. The Asia Pacific Cohort Studies Collaboration. Diabetes Care 26: 360-366, 2003
3. Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 332: 73-78, 2006 (Pubitemid 43099245)
4. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426, 2001 (Pubitemid 32681484)
5. Valmadrid CT, Klein R, Moss SE, Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160: 1093-1100, 2000 (Pubitemid 30227018)
6. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, Jardine M, Gallagher M, Turnbull F, Chalmers J, Craig J, Huxley R: The relationship between proteinuria and coronary risk: A systematic review and meta-analysis. PLoS Med 5: e207, 2008
7. Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC, Huxley R: Proteinuria and stroke: A meta-analysis of cohort studies. Am J Kidney Dis 53: 417-425, 2009
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004 (Pubitemid 39268908)
9. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 51: 1285-1295, 2004 (Pubitemid 39258422)
10. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003
11. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
12. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
13. Canadian Diabetes Association: 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 32[Suppl 1]: S126-S133, 2008. Available at: http://www. diabetes.ca/files/cpg2008/cpg-2008. pdf
14. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M: Cholesterol and Recurrent Events (CARE) Trial Investigators: Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: Analysis of a previously conducted randomised trial. BMJ 332: 1426-1432, 2006
15. Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T: The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 69: 1264-1271, 2006
16. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, Levy D, Fox CS: Cross-classification of microalbuminuria and reduced glomerular filtration rate: Associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 167: 1386-1392, 2007 (Pubitemid 47052437)
17. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J: Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 167: 2490-2496, 2007 (Pubitemid 350254909)
18. Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J: Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 167: 1226-1234, 2008
19. Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A, De Santo NG: Definition of kidney dysfunction as a cardiovascular risk factor: Use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 168: 617-624, 2008
20. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 370: 829-840, 2007 (Pubitemid 47362321)
21. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008 (Pubitemid 351831357)
22. Caramori ML, Fioretto P, Mauer M: Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: An indicator of more advanced glomerular lesions. Diabetes 52: 1036-1040, 2003 (Pubitemid 36384275)
23. MacIsaac RJ, Panagiotopoulos S, McNeil KJ, Smith TJ, Tsalamandris C, Hao H, Matthews PG, Thomas MC, Power DA, Jerums G: Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 29: 1560-1566, 2006 (Pubitemid 44127581)
24. Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43: 649-655, 1994 (Pubitemid 24138777)
25. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
26. Stehouwer CD, Smulders YM: Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 17: 2106-2111, 2006 (Pubitemid 44141899)
27. Jefferson JA, Shankland SJ, Pichler RH: Proteinuria in diabetic kidney disease: A mechanistic viewpoint. Kidney Int 74: 22-36, 2008 (Pubitemid 351841893)
28. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM: Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 9: 827-833, 1995
29. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 31[Suppl]: S29-S34, 1991
30. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group: Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: The importance of urinary albumin excretion. Nephrol Dial Transplant 23: 3851-3858, 2008
31. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110: 921-927, 2004 (Pubitemid 39128617)
32. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198-202, 2005
33. de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen C, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J, ADVANCE Collaborative Group: Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol 20: 883-892, 2009
34. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589, 2008
35. Thomas MC, Atkins R: Assessment and management of hypertension in patients with type 2 diabetes. Intern Med J 39: 143-149, 2009
36. Asia Pacific Cohort Studies Collaboration, Kengne AP, Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Gu DF, Suh I, Woodward M: Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens 25: 1205-1213, 2007 (Pubitemid 46918799)
37. Rationale and design of the ADVANCE study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation. J Hypertens Suppl 19: S21-S28, 2001
38. Cupples LA, D'Agostino RB, Anderson K, Kannel WB: Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 7: 205-222, 1988
39. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, Macmahon S, Neal B, PROGRESS Collaborative Group: Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 24: 1201-1208, 2006 (Pubitemid 43772329)
40. Barzi F, Woodward M: Imputations of missing values in practice: Results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol 160: 34-45, 2004 (Pubitemid 38856799)
41. Easton DF, Peto J, Babiker AG: Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10: 1025-1035, 1991
42. Woodward M: Epidemiology: Study Design and Data Analysis, 2nd Ed., Boca Raton, Chapman and Hall/CRC Press, 2005